Doctors Tell Ducey Hydroxychloroquine Has 90% Chance Of Helping COVID-19 Patients

States making it difficult for doctors to prescribe these medications.

The Association of American Physicians and Surgeons let Governor Doug Ducey know in a letter  that treating COVID-19 patients with the anti-malaria drugs chloroquine (CQ) and hydroxychloroquine (HCQ, Plaquenil®) seems to be working.

In early April, Gov. Doug Ducey issued an executive order making it easier to get a refill on necessary prescriptions, but tightened up the requirements to fill out a prescription for chloroquine as a possible treatment for COVID-19.

RELATED ARTICLE: The Media Were Too Busy Attacking Trump To Cover A Potential Coronavirus Breakthrough

To date, the total number of reported patients treated with HCQ, with or without zinc and the widely used antibiotic azithromycin, is 2,333, writes AAPS, in observational data from China, France, South Korea, Algeria, and the U.S. Of these, 2,137 or 91.6 percent improved clinically. There were 63 deaths, all but 11 in a single retrospective report from the Veterans Administration where the patients were severely ill.

RELATED ARTICLE:

Police Investigating Death of Arizona Man From Chloroquine Phosphate

The Mesa City Police Department’s homicide division is investigating the death of Gary Lenius, the Arizona man whose wife served him soda mixed with fish tank cleaner in what she claimed was a bid to fend off the coronavirus. A detective handling the case confirmed the investigation to the Washington Free Beacon on Tuesday after requesting a recording of the Free Beacon’s interviews with Lenius’s wife, Wanda.

The antiviral properties of these drugs have been studied since 2003. Particularly when combined with zinc, they hinder viral entry into cells and inhibit replication. They may also prevent overreaction by the immune system, which causes the cytokine storm responsible for much of the damage in severe cases, explains AAPS. HCQ is often very helpful in treating autoimmune diseases such as lupus and rheumatoid arthritis.

Additional benefits shown in some studies, AAPS states, is to decrease the number of days when a patient is contagious, reduce the need for ventilators, and shorten the time to clinical recovery.

 

Peer-reviewed studies published from January through April 20, 2020, provide clear and convincing evidence that HCQ may be beneficial in COVID-19, especially when used early, states AAPS. Unfortunately, although it is perfectly legal to prescribe drugs for new indications not on the label, the Food and Drug Administration (FDA) has recommended that CQ and HCQ should be used for COVID-19 only in hospitalized patients in the setting of a clinical study if available. Most states are making it difficult for physicians to prescribe or pharmacists to dispense these medications.

As the letter to Gov. Ducey notes, “Many nations, including Turkey and India, are protecting medical workers and contacts of infected persons prophylactically. According to worldometers.info, deaths per million persons from COVID-19 as of Apr 27 are 167 in the U.S., 33 in Turkey, and 0.6 in India.”

After began using HCQ, a trend break and sharp reduction in their COVID-19 case fatality rate occurred.

Vaccines and results of randomized double-blind controlled trials of new drugs are at best months away. But patients are dying now, while affordable, long-used drugs would be available except for government restrictions, AAPS states.

About ADI Staff Reporter 15859 Articles
Under the leadership of Editor-in -Chief Huey Freeman, our team of staff reporters bring accurate,timely, and complete news coverage.